Drug intelligence / Profile preview

Amorphophallus konjac ethyl acetate fraction

Development stage
Preclinical
Modality
Small Molecules
Administration
Topical, Oral, Buccal, Intraarterial, Intravenous, Intraperitoneal, Sublingual, Rectal, Inhalation
01

Overview

Amorphophallus konjac ethyl acetate fraction is a specific extract derived from the *Amorphophallus konjac* plant, a species native to Southeast Asia with a history of traditional medicinal use. This fraction is rich in polyphenolic compounds, including isochlorogenic acid A, isochlorogenic acid C, apigenin, and chrysin. Research indicates that this fraction exhibits anti-cancer properties, primarily by inducing ferroptosis, a form of programmed cell death, in cancer cells. The mechanism involves increasing oxidative stress markers such as reactive oxygen species (ROS), malondialdehyde (MDA), and ferrous iron (Fe²⁺), while decreasing glutathione (GSH) levels. It also upregulates the expression of key ferroptosis-related genes, including heme oxygenase-1 (HMOX-1), CHAC1, and NOX1, with the identified bioactive compounds showing high affinity for HMOX-1. Studies have demonstrated its anti-proliferative effects in breast cancer and lung cancer cell models.

Other names
A. konjac ethyl acetate fraction
02

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)ESR1 (ERα)

Beyond the preview

Go deeper on Amorphophallus konjac ethyl acetate fraction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amorphophallus konjac ethyl acetate fraction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call